| Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments S Tesfaye, AJM Boulton, PJ Dyck, R Freeman, M Horowitz, P Kempler, ... Diabetes care 33 (10), 2285, 2010 | 3307 | 2010 |
| Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management V Spallone, D Ziegler, R Freeman, L Bernardi, S Frontoni, R Pop‐Busui, ... Diabetes/metabolism research and reviews 27 (7), 639-653, 2011 | 1131 | 2011 |
| Treatment of symptomatic diabetic polyneuropathy with the antioxidant α‐lipoic acid: a meta‐analysis D Ziegler, H Nowak, P Kempler, P Vargha, PA Low Diabetic Medicine 21 (2), 114-121, 2004 | 1100 | 2004 |
| GUIDE study: double‐blind comparison of once‐daily gliclazide MR and glimepiride in type 2 diabetic patients G Schernthaner, A Grimaldi, U Di Mario, J Drzewoski, P Kempler, ... European journal of clinical investigation 34 (8), 535-542, 2004 | 482 | 2004 |
| Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study P Kempler, S Tesfaye, N Chaturvedi, LK Stevens, DJ Webb, S Eaton, ... Diabetic Medicine 19 (11), 900-909, 2002 | 321 | 2002 |
| Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus DR Witte, S Tesfaye, N Chaturvedi, SEM Eaton, P Kempler, JH Fuller, ... Diabetologia 48, 164-171, 2005 | 303 | 2005 |
| Retinopathy and vision loss in insulin-dependent diabetes in Europe: the EURODIAB IDDM Complications Study AK Sjølie, J Stephenson, S Aldington, E Kohner, H Janka, L Stevens, ... Ophthalmology 104 (2), 252-260, 1997 | 284 | 1997 |
| Methods of investigation for cardiac autonomic dysfunction in human research studies L Bernardi, V Spallone, M Stevens, J Hilsted, S Frontoni, R Pop‐Busui, ... Diabetes/metabolism research and reviews 27 (7), 654-664, 2011 | 228 | 2011 |
| Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C β-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double … AI Vinik, V Bril, P Kempler, WJ Litchy, S Tesfaye, KL Price, EJ Bastyr III, ... Clinical therapeutics 27 (8), 1164-1180, 2005 | 224 | 2005 |
| Effectiveness of different benfotiamine dosage regimens in the treatment of painful diabetic neuropathy G Winkler, B Pál, E Nagybégányi, I Öry, M Porochnavec, P Kempler Arzneimittelforschung 49 (03), 220-224, 1999 | 195 | 1999 |
| Toronto Diabetic Neuropathy Expert Group Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments S Tesfaye, AJ Boulton, PJ Dyck, R Freeman, M Horowitz, P Kempler, ... Diabetes Care 33 (10), 2285-2293, 2010 | 179 | 2010 |
| Diabetic neuropathy: new strategies for treatment T Várkonyi, P Kempler Diabetes, obesity and metabolism 10 (2), 99-108, 2008 | 162 | 2008 |
| Neuropathies. Pathomechanism, clinical presentation, diagnosis, therapy P Kempler Springer, 2002 | 160 | 2002 |
| Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations D Ziegler, S Tesfaye, V Spallone, I Gurieva, J Al Kaabi, B Mankovsky, ... Diabetes research and clinical practice 186, 109063, 2022 | 155 | 2022 |
| Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes G Schernthaner, N Shehadeh, AS Ametov, AV Bazarova, F Ebrahimi, ... Cardiovascular diabetology 19, 1-17, 2020 | 150 | 2020 |
| Painful diabetic neuropathy S Tesfaye, P Kempler Diabetologia 48, 805-807, 2005 | 144 | 2005 |
| Whither pathogenetic treatments for diabetic polyneuropathy? AJM Boulton, P Kempler, A Ametov, D Ziegler Diabetes/Metabolism Research and Reviews 29 (5), 327-333, 2013 | 137 | 2013 |
| Noninvasive evaluation of neural impairment in subjects with impaired glucose tolerance Z Putz, AG Tabak, N Toth, I Istenes, N Nemeth, RA Gandhi, Z HERManyi, ... Diabetes Care 32 (1), 181-183, 2009 | 133 | 2009 |
| A simple new non‐invasive sweat indicator test for the diagnosis of diabetic neuropathy N Papanas, AJM Boulton, RA Malik, C Manes, O Schnell, V Spallone, ... Diabetic Medicine 30 (5), 525-534, 2013 | 111 | 2013 |
| Prevalence and management of hypertension in type 1 diabetes mellitus in Europe: the EURODIAB IDDM Complications Study F Collado‐Mesa, HM Colhoun, LK Stevens, J Boavida, JB Ferriss, ... Diabetic Medicine 16 (1), 41-48, 1999 | 111 | 1999 |
